Democratic senators call on RFK Jr. to keep rule allowing Medicare coverage of anti-obesity drugs
5 Articles
5 Articles
Democratic senators call on RFK Jr. to keep rule allowing Medicare coverage of anti-obesity drugs
A group of Democratic senators are calling on Health and Human Services Secretary Robert F. Kennedy Jr. to keep a proposed Biden-era rule that would have allowed Medicare and Medicaid to cover drugs used to treat obesity after the Trump administration decided not to finalize it. Democratic Sens. Jeff Merkley (Ore.), Amy Klobuchar (Minn.), Cory…
Dems demand RFK Jr. preserve Medicare coverage of obesity drugs as Pharma profits face big hit · American Wire News
Democrat senators are begging Health and Human Services Secretary (HHS) Robert F. Kennedy Jr. to keep a proposed Biden-era rule pertaining to obesity drugs. In November, the Biden administration proposed a rule that would have allowed Medicare and Medicaid to cover anti-obesity drugs such as Ozempic. The Biden administration has proposed a new rule enabling Medicare and Medicaid to cover weight-loss drugs like Ozempic. If approved, the rule wou…
Anti-consumption agents: Tirzepatide and semaglutide for treating obesity-related diseases and addictions, and improving life expectancy
American culture encourages overconsumption, fueled by ubiquitous availability and pervasive marketing of ultra-processed foods and other addictive su…
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats – DG Verifications & Stats
Hundreds of thousands of Americans stand to soon lose their access to cheaper weight-loss drugs, with a federal crackdown on copycat versions threatening to disrupt treatment and raise costs. The Food and Drug Administration has ordered producers and sellers of the less expensive products to wind down operations in the coming weeks now that it has declared there are no longer shortages of the blockbuster drugs Wegovy and Zepbound. Produced throu…
Coverage Details
Bias Distribution
- 33% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage